服薬遵守監視市場 第1版

出版:Berg Insight(ベルグインサイト社) 出版年月:2023年10月

The Medication Compliance Monitoring Market – 1st Edition

服薬遵守監視市場 第1版

ページ数120
図表数33
価格(PDF+Excel) 
 シングルユーザライセンスEur 1,500
 2-10ユーザライセンスEur 2,250
 コーポレートライセンスEur 3,000
種別英文調査報告書

お問合せ・ご注文 価格・納期について

Berg Insight(ベルグインサイト)「服薬遵守管理市場 第1版 – The Medication Compliance Monitoring Market – 1st Edition」は世界の服薬遵守監視(服薬コンプライアンスモニタリング)市場を調査し、市場概況や主要企業情報などを分析・解説し、また服薬遵守監視市場予測結果を提供します。

当レポートの特長

  • 主要市場プレイヤとの膨大なインタビューと基に分析・解説
  • 主要服薬遵守監視用デバイスおよびサービス情報
  • 服薬遵守監視のエコシステムにおける主要プレイヤ43社の戦略
  • 北米、欧州、その他の地域(RoW)における市場ダイナミクス
  • 医療機器とシームレスに統合させる技術の解説
  • 新規服薬アドヒアランス監視分野におけるビジネス機会を評価
  • 今後の市場および技術開発予測

主な掲載内容

  • エグゼクティブサマリー
  • 慢性疾患の課題
    • 慢性疾患
      • 循環器疾患
      • 慢性呼吸器疾患
      • 糖尿病
    • 医療システム
      • 北米の医療システム
      • 欧州の医療システム
      • アジア太平洋地域の医療システム
    • 法規制環境
      • 北米の法規制環境
      • 欧州の法規制環境
      • その他の主要地域における法規制環境
      • 医療データ規制
      • 標準化
      • 報酬環境
    • 服薬遵守監視(コンプライアンスモニタリング)
      • 市場概観
      • フォームファクタとユースケース
      • 既存の服薬遵守監視技術における課題
      • 注射による服薬ソリューション提供会社
        • Beta Bionics
        • Bigfoot Biomedical
        • Biocorp
        • Credence MedSystems
        • Eli Lilly and Company
        • Innovation Zed
        • Insulet Corporation
        • Medtronic
        • Medtrum Technologies
        • Merck Group
        • Noble International (Aptar Group)
        • Novo Nordisk
        • Phillips-Medisize
        • Roche
        • Tandem Diabetes Care
        • Ypsomed
      • 吸入による服薬ソリューション提供会社
        • Adherium
        • Amiko Digital Health
        • Aptar Group
        • Cognita Labs
        • FindAir
        • NuvoAir
        • Propeller Health
        • Teva Pharmaceutical Industries
      • 薬瓶およびディスペンサーによる服薬ソリューション提供会社
        • AARDEX Group
        • AceAge
        • AdhereTech
        • Compliance Meds Technologies
        • Evondos Group
        • Hero Health
        • Information Mediary Corporation
        • iZafe Group
        • Legrand Care
        • Medimi
        • MedMinder
        • MedReady
        • PharmAdva
        • SMRxT
        • Spencer Health Solutions
        • Vaica
      • 服薬遵守向けパッケージソリューション提供会社
        • Schreiner MediPharm
        • WestRock
      • デジタルピル
        • etectRx
    • 市場予測および動向
      • ベンダ環境
      • 市場分析および予測
      • 市場動向

Report Overview

The Medication Compliance Monitoring Market is a new report from Berg Insight that gives first-hand insights into the adoption of wireless solutions that help patients to improve medication adherence. This strategic research report from Berg Insight provides you with 120 pages of unique business intelligence including 5-year industry forecasts and expert commentary on which to base your business decisions.

How should the mobile industry address the vast business opportunity in wireless healthcare monitoring? There were 4.4 million connected medication compliance monitoring devices being used worldwide at the end of 2022. The market is forecasted to grow at a compound annual growth rate (CAGR) of 13.2 percent during the next years to reach an installed base of 8.2 million units by 2027. Medication compliance monitoring solutions include injected medication solutions, inhaled medication solutions as well as pill bottles and dispensers. Learn more about how wireless technology can become seamlessly integrated with these devices in this 120-page in-depth report.

This report will allow you to:

  • Profit from numerous executive interviews with market leading companies.
  • Learn about key medication compliance monitoring devices and services.
  • Study the strategies of 43 key players in the medication compliance monitoring ecosystem.
  • Understand the market dynamics in North America, Europe and the Rest of World.
  • Comprehend how technology can become seamlessly integrated with medical devices.
  • Evaluate the business opportunities in the emerging medication adherence monitoring segment.
    Predict future market and technology developments.

Improving drug adherence with connected medication monitoring devices

Digital health innovations improve health outcomes for the ageing population and people with chronic diseases, such as asthma, chronic obstructive pulmonary disease (COPD), diabetes, cancer and heart diseases. The global population is ageing and 1 in 6 people in the world will be aged 60 years or over by 2030. It is widely demonstrated that medication compliance monitoring solutions can ease the burden on society by enabling value-based care and allowing people to live independently for longer. The definition of medication compliance monitoring includes products and services that assist the patients in adhering to a medication regimen. Medication compliance monitoring solutions include injected medication solutions, inhaled medication solutions, and pill bottles and dispensers. Medication compliance monitoring solutions incorporate connectivity, a companion smartphone application, and algorithms to personalize patient care in real-time.

At the end of 2022, there were 4.4 million connected medication compliance monitoring devices being used worldwide. The market is forecasted to grow at a compound annual growth rate (CAGR) of 13.2 percent during the next years to reach an installed base of 8.2 million units by 2027. Berg Insight estimates that the global medication compliance monitoring solution market was worth US$ 4.6 billion in 2022. The market is expected to grow at a CAGR of 12.5 percent in the next years to reach US$ 8.4 billion in 2027.

服薬遵守監視(服薬コンプライアンスモニタリング)デバイス市場予測

Injected medication solutions is the largest segment corresponding to 3.6 million connected devices at the end of 2022. Injected medication solutions are offered in different forms such as insulin pumps, pens, autoinjectors, smart buttons, add-on sensors and pen caps. Notable vendors include top players by installed base such as Medtronic, Insulet and Tandem Diabetes. Additional key companies operating in this segment are Eli Lilly and Company, Merck Group, Noble International, Novo Nordisk, Phillips-Medisize and Roche. The total installed base of inhaled medication solutions reached at the same time 181,000 devices worldwide in 2022. This market segment includes connected devices such as inhalers as well as smart inhaler sensors. The digital respiratory market is in an emerging state with multiple solution providers operating in this segment. Leading vendors of drug adherence solutions for inhaled medication include Propeller Health, Adherium, Teva Pharmaceutical Industries and Aptar Group, as well as Amiko Digital Health, FindAir, Cognita Labs and NuvoAir. The pill bottle and dispenser solution market reached an installed base of 640,000 units at the end of 2022.

This segment includes pill boxes, automatic medication dispensers, pill bottles and smart blisters that assist in reminding, dispensing and recording the medication-taking behaviour of a patient. The pill bottle and dispenser solution segment is a fragmented market that is evolving quickly and includes both consumer-oriented technology companies and traditional healthcare incumbents such as MedReady, Evondos, Hero Health, Compliance Meds Technologies, AdhereTech, MedMinder and Spencer Health Solutions.

The market for connected medication management solutions represents an interesting growth opportunity for companies from several markets. The use of injected medication solution segment has thus far gained most traction, but different connected solutions for pills and inhaled medication are increasingly adopted. The drive behind remote patient monitoring is anticipated to further support the growth of such solutions in the coming years. The growing market opportunities attract the interest of new entrants from consumer-oriented technology companies that want to expand into the healthcare industry as well as traditional healthcare incumbents that want to expand their operations outside the hospitals and into the patients’ homes.

The global market for medication compliance management solutions is affected by several trends and developments that will have an impact on the competitive landscape during the forecast period. Changing demographics is driving the demand for home care, while technological developments and regulatory changes affect the competitive landscape for solution vendors. One major transition has been from traditional drug delivery to smart drug delivery, which has encouraged companies to adopt connected solutions. At the same time, the industry is becoming more patient-centric which calls for integrated systems and improved interoperability of connected care solutions. New companies are entering the connected care market and connected medication management solutions are today in the centre of attention for start-ups.

Table of Contents

Executive Summary

1 The Challenge of Chronic Diseases

1.1 Introduction
1.1.1 The ageing population
1.2 Chronic diseases
1.2.1 Cardiovascular diseases
1.2.2 Chronic respiratory diseases
1.2.3 Diabetes
1.3 Healthcare systems
1.3.1 Healthcare in North America
1.3.2 Healthcare in Europe
1.3.3 Healthcare in Asia-Pacific
1.4 The regulatory environment
1.4.1 Regulatory environment in North America
1.4.2 Regulatory environment in Europe
1.4.3 Regulatory environment in other major markets
1.4.4 Medical data regulations
1.4.5 Standardisation
1.5 The reimbursement environment

2 Medication Compliance Monitoring

2.1 Market overview
2.2 Form factors and use cases
2.2.1 Injected medication solutions
2.2.2 Inhaled medication solutions
2.2.3 Pill bottle and dispenser solutions
2.3 Challenges with existing medication compliance technologies
2.4 Injected medication solution providers
2.4.1 Beta Bionics
2.4.2 Bigfoot Biomedical
2.4.3 Biocorp
2.4.4 Credence MedSystems
2.4.5 Eli Lilly and Company
2.4.6 Innovation Zed
2.4.7 Insulet Corporation
2.4.8 Medtronic
2.4.9 Medtrum Technologies
2.4.10 Merck Group
2.4.11 Noble International (Aptar Group)
2.4.12 Novo Nordisk
2.4.13 Phillips-Medisize
2.4.14 Roche
2.4.15 Tandem Diabetes Care
2.4.16 Ypsomed
2.5 Inhaled medication solution providers
2.5.1 Adherium
2.5.2 Amiko Digital Health
2.5.3 Aptar Group
2.5.4 Cognita Labs
2.5.5 FindAir
2.5.6 NuvoAir
2.5.7 Propeller Health
2.5.8 Teva Pharmaceutical Industries
2.6 Pill bottle and dispenser solution providers
2.6.1 AARDEX Group
2.6.2 AceAge
2.6.3 AdhereTech
2.6.4 Compliance Meds Technologies
2.6.5 Evondos Group
2.6.6 Hero Health
2.6.7 Information Mediary Corporation
2.6.8 iZafe Group
2.6.9 Legrand Care
2.6.10 Medimi
2.6.11 MedMinder
2.6.12 MedReady
2.6.13 PharmAdva
2.6.14 SMRxT
2.6.15 Spencer Health Solutions
2.6.16 Vaica
2.7 Medication compliance packaging solution providers
2.7.1 Schreiner MediPharm
2.7.2 WestRock
2.8 Digital Pills
2.8.1 etectRx

3 Market Forecasts and Trends

3.1 Vendor landscape
3.2 Market analysis and forecasts
3.2.1 Injected medication compliance monitoring solutions
3.2.2 Inhaled medication compliance monitoring solutions
3.2.3 Pill bottle and dispenser solutions
3.3 Market trends
3.3.1 The market for connected medication management is gaining traction
3.3.2 Launch of AI-based inhalers are revolutionizing the respiratory care market
3.3.3 COVID-19 became a catalyst for the growth of mHealth solutions
3.3.4 Healthcare staff shortages calls for efficient healthcare
3.3.5 Advancing ingestible biosensor technology
3.3.6 From remote patient monitoring to data-driven patient engagement
3.3.7 Solution vendors show interest in sustainability
3.3.8 Favourable policies that align financial incentives are driving RPM adoption
3.3.9 A growing market and new entrants lead to a changing market landscape
3.3.10 Shift in preference from traditional drug delivery to smart drug delivery
3.3.11 BYOD has become a common option for telehealth
3.3.12 M&As drive consolidation in the connected medication technology landscape
3.3.13 Growing investment interest in the digital health market
3.3.14 An ageing population increases healthcare expenditures

List of Acronyms and Abbreviations

List of Figures

Figure 1.1: Population by age group and region………….. 5
Figure 1.2: Prevalence of diabetes by region (World 2021) ………… 9
Figure 1.3: Share of the population covered by private health insurance (2021) …. 10
Figure 1.4: Total health expenditure per capita by country (2021)……… 12
Figure 1.5: Total and per capita healthcare expenditure by country (North America 2021) … 13
Figure 1.6: Healthcare spending by type of service and product (Canada 2022) …… 14
Figure 1.7: Health insurance coverage by type of insurance (US 2021)…… 15
Figure 1.8: Healthcare spending by type of service and product (US 2021) …….. 16
Figure 1.9: Summary of RPM and RTM codes ………… 26
Figure 2.1: Common causes of medication non-adherence ………… 30
Figure 2.2: Examples of medication management solutions………… 31
Figure 2.3: Pill bottle and dispenser solution types………….. 37
Figure 2.4: Injected medication solution providers and their product offerings…. 39
Figure 2.5: Current and forthcoming insulin-pump devices ………. 40
Figure 2.6: Bigfoot Biomedical Unity system…………… 42
Figure 2.7: Eli Lilly’s Tempo Personalized Diabetes Management Platform …… 46
Figure 2.8: Medtronic Diabetes revenues by sub-segment (World 2022)……. 49
Figure 2.9: Phillips-Medisize Aria Smart Autoinjector ……….. 54
Figure 2.10: Roche mySugr app……………. 56
Figure 2.11: The FindAir asthma management app and inhaler sensor …… 63
Figure 2.12: Propeller Health’s asthma management app and inhaler sensor ….. 66
Figure 2.13: Teva Respiratory Digihaler system …………. 68
Figure 2.14: The AdhereTech smart pill bottle…………. 72
Figure 2.15: The Hero Health smart medication dispenser……….. 77
Figure 2.16: The Spencer SmartHub from Spencer Health Solutions……. 84
Figure 2.17: Schreiner MediPharm Smart Blister Wallet and Smart Blister Card….. 87
Figure 3.1: Medication management solutions by form factor……… 92
Figure 3.2: Medication compliance monitoring devices by segment (World 2021–2027) … 94
Figure 3.3: Medication compliance monitoring market value (World 2021–2027)…… 95
Figure 3.4: Leading injected medication solution providers (2022) ………. 97
Figure 3.5: Leading connected pill bottle and dispenser solution providers (World 2022) …. 99
Figure 3.6: Strategic activity in the connected medication compliance market (2019–2023).. 111
Figure 3.7: Elderly population (65+) as a percentage of total population ……. 114